- Ongoing Phase 2 study enrolling 102 patients in the U.S. and South Korea, with more than 50% of participants identified as Asian - Selectively inhibits collagen synthesis via PRS targeting, aiming to suppressing fibrosis progression SEOUL, June 4, 2025 /PRNewswire/ -- Daewoong...
Hence then, the article about daewoong pharmaceutical presents phase 2 clinical trial poster on bersiporocin at ats 2025 highlights global patient demographics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Daewoong Pharmaceutical Presents Phase 2 Clinical Trial Poster on 'Bersiporocin' at ATS 2025, Highlights Global Patient Demographics )
Also on site :
- Hollywood mourns loss of beloved makeup artist Jasen Kaplan
- Rose Parade Viewers 'Floored' by 'Disaster' Finale Performance: 'Yikes'
- Taylor Swift attends Este Haim’s NYE wedding to Jonathan Levin at boutique hotel in California